ACTNOVA (액트노바)
Daejeon, South Korea
ACTNOVA specializes in AI-driven animal behaviour analysis using its software platform, Actverse. By leveraging artificial intelligence and biosensors, the company enables researchers to perform precise, automated symptom analysis for neurodegenerative diseases such as dementia and Parkinson's. Through collaborations with institutions like MIT and the Korea Brain Research Institute, ACTNOVA aims to accelerate the biotech industry's digital transformation. Their B2B solutions support corporate and healthcare professional users in gathering critical data for medical research and diagnosis, bridging animal models with human therapeutic development.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2019
- Website
- www.actnova.io/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of ACTNOVA (액트노바)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now